Sommaire

• • ·Editorial board

    Page :A9

    
• • ·Table of contents

    Page :A12

    
• • ·Information for readers

    Page :A46

    
• • ·JAAD Case Reports article list

    Page :A48

    
• • ·Journal based CME instructions and information

    Page :A62

    

• Continuing Medical Education

  • ·Skin cancer: Primary, secondary, and tertiary prevention. Part I

    Page :255-268

    Mariana Perez, Juanita Arango Abisaad, Kristina D. Rojas, Michael A. Marchetti, Natalia Jaimes

    Résumé Résumé Plan Plan  
  • ·CME examination Skin cancer quiz part 1: Question

    Page :269

    
  • ·Skin cancer quiz part 1: Answer

    Page :270

    
  • ·Skin cancer: Primary, secondary, and tertiary prevention. Part II.

    Page :271-288

    Kristina D. Rojas, Mariana E. Perez, Michael A. Marchetti, Anna J. Nichols, Frank J. Penedo, Natalia Jaimes

    Résumé Résumé Plan Plan
  • ·CME examination Skin cancer quiz part 2: Question

    Page :289

    
  • ·Skin cancer quiz part 2: Answer

    Page :290

    

• Letter from the Editor

  • ·Letter from the editor: Meta-analysis models

    Page :291-292

    Dirk M. Elston

    

• This Month in JAAD

  • ·This Month in JAAD: August 2022

    Page :293

    Dirk M. Elston

    

• This Month in JAAD Case Reports

  • ·This Month in JAAD Case Reports: August 2022

    Page :294

    Brett Sloan

    

• This Month in JAAD International

  • ·This Month in JAAD International: August 2022: Cutaneous reactions to COVID-19 messenger RNA booster dose vaccination

    Page :295

    Jonathan Kantor

    

• A Clinician's Perspective

  • ·Pediatric longitudinal melanonychia: Delaying the bottom line

    Page :296-297

    Warren R. Heymann

    

• Original Articles

  • ·The progressive relationship between increasing Breslow thickness and decreasing survival is lost in patients with ultrathick melanomas (≥15 mm in thickness)

    Page :298-305

    Mary-Ann El Sharouni, Robert V. Rawson, Vigfús Sigurdsson, Arjen J. Witkamp, Carla H. van Gils, Richard A. Scolyer, John F. Thompson, Paul J. van Diest, Serigne N. Lo

    Résumé Résumé Plan Plan  
  • ·Phase 2 randomized, dose-ranging trial of CTP-543, a selective Janus Kinase inhibitor, in moderate-to-severe alopecia areata

    Page :306-313

    Brett King, Natasha Mesinkovska, Paradi Mirmirani, Suzanne Bruce, Steve Kempers, Emma Guttman-Yassky, Janet L. Roberts, Amy McMichael, Maria Colavincenzo, Colleen Hamilton, Virginia Braman, James V. Cassella

    Résumé Résumé Plan Plan  
  • ·Adult atopic eczema and the risk of dementia: A population-based cohort study

    Page :314-322

    Alexa Magyari, Morgan Ye, David J. Margolis, Charles E. McCulloch, Steven R. Cummings, Kristine Yaffe, Sinéad M. Langan, Katrina Abuabara

    Résumé Résumé Plan Plan  
  • ·Prevalence and factors associated with long-term remission in cutaneous lupus: A longitudinal cohort study of 141 cases

    Page :323-332

    Damien Fayard, Camille Francès, Zahir Amoura, Paul Breillat, Alexis Mathian, Patricia Senet, Annick Barbaud, Laurent Arnaud, François Chasset

    Résumé Résumé Plan Plan  
  • ·Oral tyrosine kinase 2 inhibitor PF-06826647 demonstrates efficacy and an acceptable safety profile in participants with moderate-to-severe plaque psoriasis in a phase 2b, randomized, double-blind, placebo-controlled study

    Page :333-342

    Christopher Tehlirian, Ravi Shankar P. Singh, Vivek Pradhan, Erika S. Roberts, Sanela Tarabar, Elena Peeva, Michael S. Vincent, Jeremy D. Gale

    Résumé Résumé Plan Plan  
  • ·Associations of combined lifestyle and genetic risks with incident psoriasis: A prospective cohort study among UK Biobank participants of European ancestry

    Page :343-350

    Minxue Shen, Yi Xiao, Danrong Jing, Guanxiong Zhang, Juan Su, Shuhong Lin, Xiang Chen, Hong Liu

    Résumé Résumé Plan Plan  
  • ·Phase 3 efficacy and safety of abrocitinib in adults with moderate-to-severe atopic dermatitis after switching from dupilumab (JADE EXTEND)

    Page :351-358

    Vivian Y. Shi, Tina Bhutani, Luz Fonacier, Mette Deleuran, Stephen Shumack, Hernan Valdez, Fan Zhang, Gary L. Chan, Michael C. Cameron, Natalie C. Yin

    Résumé Résumé Plan Plan  
  • ·Bullous pemphigoid: Three main clusters defining 3 outcome profiles

    Page :359-365

    Florine Guerrois, Elsa Hassan, Thomas Bettuzzi, Vannina Seta, Claire Goulvestre, Lamia Jelti, Thibaut Belmondo, Pierre Wolkenstein, Selim Aractingi, Saskia Ingen-Housz-Oro, Nicolas Dupin

    Résumé Résumé Plan Plan  

• Pediatric Dermatology

  • ·Clinical features and natural course of pediatric longitudinal melanonychia: A retrospective cohort study in Korea

    Page :366-372

    Ji Su Lee, Sungbum Kim, Dong Hyo Kim, Ji Won Lee, Je-Ho Mun, Si-Hyung Lee

    Résumé Résumé Plan Plan  

• From the Academy

  • ·Focused update: Guidelines of care for the management of actinic keratosis

    Page :373

    Daniel B. Eisen, Robert P. Dellavalle, Lindsy Frazer-Green, Todd E. Schlesinger, Melissa Shive, Peggy A. Wu

    Résumé Résumé Plan Plan

• Reviews

  • ·Assessing signs of torture: A review of clinical forensic dermatology

    Page :375-380

    Patrícia D. Deps, Hugo Pessotti Aborghetti, Taís Loureiro Zambon, Victória Coutinho Costa, Julienne Dadalto dos Santos, Simon M. Collin, Philippe Charlier

    Résumé Résumé Plan Plan  
  • ·Antihistamine safety in older adult dermatologic patients

    Page :381-386

    Madison Grinnell, Kyla N. Price, Amit Shah, Daniel C. Butler

    Résumé Résumé Plan Plan  

• Research Letters

  • ·Incidence of skin cancers in patients with eczema treated with ultraviolet phototherapy

    Page :387-389

    Tashmeeta Ahad, Elle Yueqiao Wang, Yi A. Liu, Tim K. Lee, Harvey Lui, Richard I. Crawford, Sunil Kalia

     
  • ·Placebo group regrowth rate in alopecia areata clinical trials: A systematic review and meta-analysis

    Page :389-390

    Jane J. Han, Sheena Desai, Sara J. Li, Karen J. Lee, Carol Mita, Cara Joyce, Arash Mostaghimi

     
  • ·Maintenance, withdrawal, and re-treatment with ritlecitinib and brepocitinib in patients with alopecia areata in a single-blind extension of a phase 2a randomized clinical trial

    Page :390-393

    Elena Peeva, Emma Guttman-Yassky, Anindita Banerjee, Rodney Sinclair, Lori Ann Cox, Linda Zhu, Hua Zhu, Michael Vincent, Brett King

     
  • ·From the Cochrane Library: Systemic treatments for eczema, a network meta-analysis

    Page :393-395

    Sarah Guo, Marie Donaldson, Alex G. Ortega-Loayza, Ratree Sawangjit, Nathorn Chaiyakunapruk, Brandon L. Adler

    
  • ·The association between frontal fibrosing alopecia, sunscreen, and moisturizers: A systematic review and meta-analysis

    Page :395-396

    Jalal Maghfour, Marissa Ceresnie, Justin Olson, Henry W. Lim

    
  • ·Randomized clinical trial of low-dose oral minoxidil for the treatment of female pattern hair loss: 0.25 mg versus 1 mg

    Page :396-399

    Marcella Nascimento e Silva, Paulo Müller Ramos, Márcio Roberto Silva, Rafaella Nascimento e Silva, Nádia Rezende Barbosa Raposo

    
  • ·Treatment of immune checkpoint inhibitor–mediated psoriasis: A systematic review

    Page :399-400

    Jordan Taylor Said, Scott Andrew Elman, Lourdes Maria Perez-Chada, Carol Mita, Joseph F. Merola, Nicole R. LeBoeuf

    
  • ·Topical Janus kinase-signal transducers and activators of transcription inhibitor tofacitinib is effective in reducing nonatopic dermatitis chronic itch: A case series

    Page :400-403

    Teresa Ju, Angelina Labib, Ashley Vander Does, Gil Yosipovitch

    
  • ·Female sex is associated with higher rates of dermatologic adverse events among patients with melanoma receiving immune checkpoint inhibitor therapy: A retrospective cohort study

    Page :403-406

    Ai-Tram N. Bui, Amina Bougrine, Elizabeth I. Buchbinder, Anita Giobbie-Hurder, Nicole R. LeBoeuf

     
  • ·No increased incidence of Clostridium difficile infection among patients with hidradenitis suppurativa treated with systemic clindamycin

    Page :406-407

    Ruby Kwak, Christina G. Lopez, Megan H. Noe, Vinod E. Nambudiri, Alexandra P. Charrow

    
  • ·Topical sirolimus therapy for nevus sebaceus and epidermal nevus: A case series

    Page :407-409

    Amanda G. Zhou, Richard J. Antaya

     
  • ·Association between topical corticosteroid use and fracture risk among pediatric patients with atopic dermatitis

    Page :409-411

    Reese L. Imhof, Amy L. Weaver, Jennifer St. Sauver, Jennifer Hand, Dawn Marie R. Davis, Megha M. Tollefson

     
  • ·Disparities in availability of skin therapies found in public assistance formularies

    Page :411-417

    Michael Kamara, Alyce M. Kuo, Sarah L. Stein, Esteban Fernandez Faith, Janice L. Pelletier, Sharon Jacob, Mercedes E. Gonzalez, Nanette B. Silverberg, PeDRA Skin of Color Special Interest Group

    
  • ·Preliminary definition of flare in cutaneous lupus erythematosus using the Cutaneous Lupus Erythematosus Disease Area and Severity Index

    Page :418-419

    Emily Keyes, Robert Borucki, Rui Feng, Madison Grinnell, Thomas Vazquez, DeAnna Diaz, Victoria P. Werth

    
  • ·Comparative efficacy of intralesional Candida antigen, intralesional bivalent human papilloma virus vaccine, and cryotherapy in the treatment of common warts

    Page :419-421

    Amany Nassar, Rania Alakad, Reham Essam, Noha M. Bakr, Ahmad Nofal

     
  • ·Utilization and outcomes of an asynchronous teledermatology pilot for an inpatient rehabilitation hospital

    Page :421-423

    Michael R. Stephens, Shinjita Das, Gideon P. Smith

    
  • ·Topical 5% 5-fluorouracil versus procedural modalities for squamous cell carcinoma in situ and superficial basal cell carcinoma: A retrospective cohort analysis

    Page :423-425

    Holly Neale, Melissa Michelon, Susan Jacob, Mary Pinkston, Rebecca Ukaegbu, Waldo Zamor, Emily Morrison, April Deng, Nikki A. Levin

    
  • ·Association of obesity in early childhood with atopic dermatitis in late childhood and adolescence

    Page :426-427

    Jaya Manjunath, Jonathan I. Silverberg

    
  • ·Incidence and comorbidities of pediatric alopecia areata: A retrospective matched cohort study using the Rochester Epidemiology Project

    Page :427-429

    Nora S. Ali, Megha M. Tollefson, Christine M. Lohse, Rochelle R. Torgerson

    
  • ·Medical management of Stevens-Johnson syndrome/toxic epidermal necrolysis among North American dermatologists

    Page :429-431

    Jane J. Han, Andrew Creadore, Lucia Seminario-Vidal, Robert Micheletti, Megan H. Noe, Arash Mostaghimi

     
  • ·Synergistic effect of lymphovascular invasion and nodal involvement on prognosis in Merkel cell carcinoma: A retrospective analysis in the National Cancer Database

    Page :432-433

    Kevin A. Nguyen, Nolan J. Maloney, Jason J. Yang, Lisa C. Zaba

     
  • ·Diagnostic yield of staging brain magnetic resonance imaging is low in Merkel cell carcinoma: A single-institution cohort study

    Page :434-435

    Farees Saqlain, Sophia Z. Shalhout, Kevin S. Emerick, Howard L. Kaufman, Yen-Lin E. Chen, James C. Cusack, Kayla Wright, David Michael Miller

    
  • ·Mycophenolate mofetil versus methotrexate for vulvar lichen planus: A 10-year retrospective cohort study demonstrates comparable efficacy and tolerability

    Page :436-438

    Matthew L. Hrin, Nathan L. Bowers, Steven R. Feldman, William W. Huang, Rita O. Pichardo

    
  • ·Comparing antibiotic prescription rates between in-person and telemedicine visits

    Page :438-440

    Ramie Fathy, Sara Briker, Olaf Rodriguez, John S. Barbieri

    
  • ·Sunscreen use is not associated with increased blood concentrations of benzene among adults in the United States: Data from the National Health and Nutrition Examination Survey 2003-2006 and 2009-2018

    Page :440-443

    Michael S. Chang, Kevin J. Moore, Nicole Trepanowski, Tulay Koru-Sengul, Rebecca I. Hartman

    
  • ·Topical sodium thiosulfate as treatment of calcinosis cutis: Case series and systematic review

    Page :443-444

    Jose W. Ricardo, Helen Y. Sun, Mahdieh Gorji, Deshan F. Sebaratnam

    
  • ·Risk factors for and prognostic impact of positive surgical margins after excision of Merkel cell carcinoma

    Page :444-446

    Nolan J. Maloney, Kevin A. Nguyen, Naomi A. So, Sumaira Z. Aasi, Lisa C. Zaba

    Résumé Résumé  
  • ·Comparative responsiveness of cutaneous lupus erythematosus patients to methotrexate and mycophenolate mofetil: A cohort study

    Page :447-448

    Emily Keyes, Anisha Jobanputra, Rui Feng, Madison Grinnell, Thomas Vazquez, DeAnna Diaz, Victoria P. Werth

    
  • ·Racial differences in psychiatric comorbidities of rosacea: A large, urban academic center case-control study

    Page :448-451

    Julie Z. Yi, Kyla Pagani, Danitza Lukac, Stephanie Li, Hye Jin Chung, Jean S. McGee

    
  • ·Patch testing results in skin of color: A retrospective review from the Massachusetts General Hospital contact dermatitis clinic

    Page :452-454

    Cristina M. Foschi, Idy Tam, Peter C. Schalock, JiaDe Yu

    
  • ·Association of lichen planus with cardiovascular disease: A combined analysis of the UK Biobank and All of Us Study

    Page :454-456

    Audrey C. Leasure, Julian N. Acosta, Lauren H. Sansing, Kevin N. Sheth, Jeffrey M. Cohen, Guido J. Falcone

    
  • ·A novel proof-of-concept study assessing the lightening effects and safety of malassezin for treatment of facial hyperpigmentation

    Page :456-458

    Pearl E. Grimes, Jag Bhawan, Michael D. Howell, Seemal Desai, Edna Coryell, Rama Nashawati, Michael Einziger, Ann Marie Simpson, Alex Yaroshinsky, Tim Mc Craw

    
  • ·Common filaggrin gene loss-of-function variants are associated with skin cancer risk

    Page :458-460

    Ayodele Adelanwa, Ahmed Yousaf, Wei Fang, Michael S. Kolodney

    
  • ·Distribution of race and Fitzpatrick skin types in data sets for deep learning in dermatology: A systematic review

    Page :460-461

    Yong-hun Kim, Ajdin Kobic, Nahid Y. Vidal

    
  • ·Isotretinoin use for acne in obese and overweight young people: A retrospective study

    Page :461-464

    Maggie Tallmadge, Ashaki Patel, Melodee Nugent Liegl, Amy Pan, Jody Barbeau, Leah Lalor

    Résumé Résumé  
  • ·Disparities in pediatric clinical trials for acne vulgaris: A cross-sectional study

    Page :464-466

    Jeffrey Ding, Ahmed Farhan Haq, Marissa Joseph, Faisal Khosa

     
  • ·Mark, magnify, map: Improving biopsy-site photography

    Page :467-469

    Daniel M. Klufas, Mary E. Lohman, Jennifer Y. Liu, Rita Khodosh

     
  • ·Spectrum of severe ocular complications following dupilumab exposure: A perspective from the ophthalmology clinic

    Page :469-472

    Grace Sora Ahn, Kaela Acuff, Bryan K. Sun, Sally L. Baxter

     
  • ·Severe herpes simplex and varicella-zoster viral infection in patients with solid organ transplantation: A nationwide population-based cohort study with propensity score matching analysis

    Page :472-474

    Tung-Min Yu, Kuo-Ting Sun, Shiang-Cheng Kung, Brian K. Lee, Ming-Ju Wu, Cheng-Hsu Chen, Chung-Shu Sun, Ying-Chih Lo, Tsuo-Hung Lan, Chi-Yuan Li, Ting-Fang Chiu, Mei-Chen Lin, Chia-Hung Kao

     
  • ·Atopic dermatitis and the risk of eating disorders: A population-based cohort study

    Page :474-476

    Saana Kauppi, Jari Jokelainen, Markku Timonen, Kaisa Tasanen, Laura Huilaja

    
  • ·Dermatologic findings in individuals with Turner syndrome: A cross-sectional study across the lifespan

    Page :476-479

    Jordan Taylor Said, Deeti J. Pithadia, Emma Snyder, Ibrahim Elsharkawi, Angela Lin, Evelyn Lilly

    
  • ·Lack of association between CDKN2A germline mutations and survival in patients with melanoma: A retrospective cohort study

    Page :479-482

    Norbertus Anton Ipenburg, Mary-Ann El Sharouni, Remco van Doorn, Paul J. van Diest, Monique E. van Leerdam, Jasper I. van der Rhee, Jelle Goeman, Nicole A. Kukutsch, Netherlands Foundation for Detection of Hereditary Tumors collaborative investigators, Dyon G.C.T.M. Snels, Sybren Dekker, Robert L. van Leeuwen, Tondo van Rijssen, Erik Honig, Jacqueline Vink, Marianne B. Crijns, Ineke Bruynzeel, Francis P.K. Wu, Biljana Zupan-Kajcovski, Jacqueline Schuur

    
  • ·Validation of International Classification of Diseases Tenth Revision code for prurigo nodularis

    Page :482-484

    Youkyung Sophie Roh, Melika Marani, Una Choi, Nishadh Sutaria, Varsha Parthasarathy, Junwen Deng, Zachary A. Bordeaux, Matthew T. Taylor, Yevgeniy R. Semenov, Shawn G. Kwatra

    
  • ·Management of pediatric generalized pustular psoriasis using biologics: An evidence-based review

    Page :484-486

    Muskaan Sachdeva, Brian D. Rankin, Asfandyar Mufti, Jensen Yeung, Ronald Vender, Nadia J. Luca, Paivi Miettunen, Rebeka Stevenson, Alim R. Devani, Vimal H. Prajapati

     
  • ·Diagnostic utility of preferentially expressed antigen in melanoma immunohistochemistry in the evaluation of melanomas with a co-existent nevoid melanocytic population: A single-center retrospective cohort study

    Page :486-488

    Maya Farah, Hye Jin Chung

     
  • ·Bicalutamide improves minoxidil-induced hypertrichosis in female pattern hair loss: A retrospective review of 35 patients

    Page :488-490

    Anthony Moussa, Ahmed Kazmi, Laita Bokhari, Rodney D. Sinclair

    
  • ·Propranolol response in patients with segmental versus focal facial hemangiomas: A retrospective case-control study

    Page :490-491

    Florian Schmid, Peter H. Hoeger

     
  • ·Dermatologic surgery opioid prescribing recommendations in practice

    Page :492-494

    Surya A. Veerabagu, Arianna F. Yanes, Brian Cheng, Jeremy R. Etzkorn, Christopher J. Miller, Thuzar M. Shin, Joseph F. Sobanko, H. William Higgins, Stacy L. McMurray, Joanna L. Walker, Cerrene N. Giordano

     
  • ·From the Cochrane Library: Nonsurgical interventions for cutaneous Bowen disease

    Page :494-495

    Daniel M. Strock, Michelle Militello, Torunn E. Sivesind, Rubeta N. Matin, Robert P. Dellavalle

    
  • ·The efficacy and safety of Janus kinase inhibitors in patients with atopic dermatitis: A systematic review and meta-analysis

    Page :495-496

    Jingsi Chen, Jun Cheng, Huan Yang, Wei Tu, Yan Zhang, Xiaoyan Luo, Hua Wang

    

• Commentary

  • ·Response to Falotico et al’s “Biotin beware: Perils of biotin supplementation”

    Page :497

    Jacob Nosewicz, Natalie Spaccarelli, Kristen M. Roberts, Phil A. Hart, Jessica A. Kaffenberger, John C. Trinidad, Benjamin H. Kaffenberger

    
  • ·Reply to: “Special editorial: When prescribing Janus Kinase inhibitors for dermatologic conditions, be mindful of the Food and Drug Administration’s September 1, 2021, data safety communication”

    Page :498-499

    Brett A. King, Brittany G. Craiglow

    

• Ethics Journal Club

  • ·Offering unsolicited cosmetic solutions during a routine medical dermatology visit: Ethical considerations

    Page :500-501

    Daniel Mosallaei, Jane M. Grant-Kels

    

• JAAD Online

  • ·Beyond JAAD July 2022

    Page :e55

    Andrew Bronin

    Plan Plan
  • ·Side lighting to enhance the visualization of leukotrichia in vitiligo

    Page :e59

    Mohammed I. AlJasser

    Plan Plan  
  • ·Use of overhead projector sheets for vulvar dermatoscopy

    Page :e61

    Sweta Hasmukh Rambhia, Dipali Malvankar, Kinjal Deepak Rambhia, Amit Gulati

    Plan Plan  
  • ·The novel application of dropper cover for the protection of ampoules

    Page :e63

    Zhujun Shao, Chunyan Cao, Pengcheng Ma, Hongyang Li

    Plan Plan  
  • ·Surgical field exposure of the back of the ear using adhesive strips to position the ear

    Page :e65

    Chao Yue, Jian Zhong Peng

    Plan Plan  
  • ·Disposable rubber gloves that are filled or inflated for prevention of pressure sores

    Page :e67

    Ruiqi Liu, Xiaodan Zhao, Xuan Zhou

    Plan Plan  
  • ·Mechanical harvesting of perilesional normally pigmented tissue to merge donor and recipient sites for transplantation in vitiligo

    Page :e69

    Dilip Kachhawa, Nripen Kachhawa, Somesh Gupta

    Plan Plan   
  • ·Pincer flap for reconstruction of the infraorbital medial aspect of the cheek

    Page :e71

    Nataly Portilla, Felipe B. Cerci, Stanislav N. Tolkachjov

    Plan Plan  
  • ·Precise volumetric quantification using 3D stereophotogrammetry in procedural and surgical dermatology

    Page :e73

    Heidi Wat, Nisrine Imad Kawa, R. Rox Anderson, Mathew M. Avram

    Plan Plan  
  • ·Sleep disturbances in older adults with pruritic eruptions: Implications across inconsistent literature and a commentary on “Association of sleep disturbances with geriatric age in atopic dermatitis patients”

    Page :e77

    Sami Jelousi, Daniel C. Butler

    
  • ·Circulation, sensation, and hair growth: A reply

    Page :e79

    Gregory Cavanagh, Andy Goren, Carlos Gustavo Wambier

    
  • ·Comment on scalp neuropathy in androgenetic alopecia

    Page :e81

    Ralph M. Trüeb, Ngoc-Nhi C. Luu

    
  • ·Shifting focus from “what we do” to the “impact of what we do”: Application of outcome measures to routine clinical care in dermatology

    Page :e83

    Amit Garg, McKenzie A. Dirr, Gregor B.E. Jemec, John R. Ingram, Jochen Schmitt, Phyllis Spuls, Murad Alam

    
  • ·Sample CME manuscript submission: Response to the article by Pham et al entitled “Review BRAF inhibition and the spectrum of granulomatous reactions”

    Page :e85

    Marion Marcaillou, Jeremie Dion, Barouyr Baroudjian, Emilien Ezrine, Cristina Carrera, Alisa Anderle, Zoe Apalla, Azael Freites-Martinez, Cécile Pages, Celeste Lebbe, Nicolas Meyer, Vincent Sibaud, Thibault Comont

    
  • ·Reply to “Vitamin D status in scarring and nonscarring alopecia”

    Page :e89

    Shawn Afvari, Maryia Kazlouskaya, Abigail Cline

    
  • ·AUGUST 2022 iotaderma (#342)

    Page :e91

    Robert I. Rudolph

    
  • ·July 2022 iotaderma (#341)

    Page :e91

    Robert I. Rudolph